These are independent reviews of the products mentioned, but TIME receives a commission when purchases are made through affiliate links at no additional cost to the purchaser.
Wrinkle-reducer Botox now has some competition. Biotech company Revance’s Daxxify injection uses botulinum toxin, similar to Botox, but it’s also powered by peptides, amino acids that make up proteins the skin needs, and studies suggest that its effects last roughly two months longer than Botox. Daxxify has been commercially available since March, and in August, the FDA approved it for another use, which will come to market mid-2024: It can treat cervical dystonia—painful, involuntary neck muscle contractions—relieving symptoms for up to three months longer than the current treatment.
More Must-Reads from TIME
- Cybersecurity Experts Are Sounding the Alarm on DOGE
- Meet the 2025 Women of the Year
- The Harsh Truth About Disability Inclusion
- Why Do More Young Adults Have Cancer?
- Colman Domingo Leads With Radical Love
- How to Get Better at Doing Things Alone
- Michelle Zauner Stares Down the Darkness
